HomeCT9 • FRA
add
Cardiol Therapeutics Inc
Previous close
€1.09
Day range
€1.13 - €1.13
Year range
€0.60 - €2.29
Market cap
169.43M CAD
Avg Volume
1.14K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.43M | 0.28% |
Net income | -8.29M | 9.72% |
Net profit margin | — | — |
Earnings per share | -0.10 | — |
EBITDA | -8.42M | -0.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.29M | -18.48% |
Total assets | 25.45M | -18.22% |
Total liabilities | 7.87M | -28.91% |
Total equity | 17.59M | — |
Shares outstanding | 82.65M | — |
Price to book | 5.21 | — |
Return on assets | -73.53% | — |
Return on capital | -98.87% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -8.29M | 9.72% |
Cash from operations | -7.15M | -3.34% |
Cash from investing | -11.94K | -245.06% |
Cash from financing | -13.84K | -118.13% |
Net change in cash | -7.29M | -14.60% |
Free cash flow | -4.26M | -69.34% |
About
CEO
Founded
2017
Headquarters
Website
Employees
18